GS
The Goldman Sachs Group, Inc.
GS has a slight edge over MCY overall, supported by stronger modeled upside and lower modeled downside.
MCY
Mercury General Corporation
MCY offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
MCY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
MCY's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCY.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
MCY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $74.50 | -14% |
| Current | 7.4x | $86.41 | — |
| Forward | 7.6x | $86.41 | — |
| Fair | 10x | $119 | +37% |
| Expensive | 13x | $152 | +76% |
Historical ranges are pointers, not guarantees.
MCY has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over MCY on the outlook, with more favorable earnings and profitability expectations.
MCY Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect MCY's revenue to grow, but its profitability to weaken.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over MCY on earnings, with more consistent year-over-year improvement.
MCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.41 | -1.7% |
| Q3 2026 | $11.61 | +46% |
| Q2 2026 | $16.92 | +140% |
| Q1 2026 | $15.17 | +194% |
| Q4 2025 | $9.77 | +16% |
| Q3 2025 | $7.93 | -21% |
| Q2 2025 | $7.04 | +22% |
| Q1 2025 | $5.16 | +33% |
| Q4 2024 | $8.45 | +386% |
MCY earned $11.61 per share over the past year, up 46% from the year before.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over MCY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over MCY on profitability, with a higher operating margin.
MCY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | -13% |
| Q2 2026 | $1.7B | +14% |
| Q1 2026 | $1.5B | +10% |
| Q4 2025 | $1.5B | +12% |
| Q3 2025 | $1.6B | +3.6% |
| Q2 2025 | $1.5B | +13% |
| Q1 2025 | $1.4B | +9.4% |
| Q4 2024 | $1.4B | -0.6% |
MCY's revenue is growing: $1.4B last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.7% | -24 points |
| Q2 2026 | 19% | +5.5 points |
| Q1 2026 | 15% | +26 points |
| Q4 2025 | 16% | +7.2 points |
| Q3 2025 | 22% | +3.3 points |
| Q2 2025 | 14% | +8.2 points |
| Q1 2025 | -10% | -17 points |
| Q4 2024 | 9% | -8.3 points |
MCY's operating margin was −1.7% last quarter, down 24 points from the same quarter a year ago.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
MCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $372.6M | -22% |
| Q2 2026 | $201.6M | -44% |
| Q1 2026 | $308.8M | +$390.7M |
| Q4 2025 | $273.9M | +16% |
| Q3 2025 | $479.5M | +57% |
| Q2 2025 | $357.2M | +34% |
| Q1 2025 | -$81.9M | -145% |
| Q4 2024 | $236M | +9.5% |
MCY has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over MCY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
MCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | +18K shares |
| 5 years | 0% | +14K shares |
| Available history | +0.1% | +29K shares |
MCY has 55M diluted shares, about the same as a year ago.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over MCY on leverage, with a lower net debt burden relative to earnings.
MCY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.1x | Net Cash |
| Q1 2025 | -3.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
MCY has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like MCY.
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
MCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 19.1 | Oversold |
MCY's weekly RSI is 34 (neutral) and its Stochastic is 19 (oversold).
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
MCY PE vs Financial Services Sector
| Metric | MCY | Sector median | Relative |
|---|---|---|---|
| PE | 7.4x | 13x | 43% below |
| PE % | 32 | 63 | 31 pts below |
MCY has the edge over GS on valuation relative to its sector.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS has the edge over MCY on trend strength, trading above more of its moving averages.
MCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.7 | 12% below |
| 20 week MA | $102.7 | 16% below |
| 50 week MA | $97.3 | 11% below |
| 100 week MA | $81.9 | 5.5% above |
| 200 week MA | $63.2 | 37% above |
MCY has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has the edge over MCY on returns for 2026, with the stronger performance.
MCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.6 | $51.8 | +6.6% |
| 2021 | $51.8 | $51.2 | -1.2% |
| 2022 | $51.2 | $33.5 | -35% |
| 2023 | $33.5 | $37.3 | +12% |
| 2024 | $37.3 | $67.0 | +80% |
| 2025 | $67.0 | $94.0 | +40% |
| 2026 YTD | $94.0 | $86.4 | -8% |
MCY has finished higher in four of the last six years. It's down 8% so far in 2026.